Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06445387
Other study ID # AU-SBE-ASoylu-03
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 12, 2021
Est. completion date January 4, 2023

Study information

Verified date May 2024
Source Amasya University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is to examine the effect of virtual reality and ice application on the pain level due to femoral sheath extraction.


Description:

After obtaining the necessary permissions for the research, the patients who were followed up in the hemodialysis unit of X,Y, Z Hospitals were randomly divided into three groups (virtual reality glasses application, ice application and control group). Randomization: Since the number of male and female patients was wanted to be kept equal, simple randomization would not be possible, so the stratified randomization method was used. Patients were assigned to groups in equal numbers according to their femoral sheath sizes. In our clinic, size 6 and 7 femoral sheaths are applied to male patients, and number 6 femoral sheaths are applied to female patients. Male patients were assigned to equal groups according to femoral sheath size 6 and 7. Since PCI is not performed in our clinic on weekends except for emergencies, data were collected during working hours during a five-day weekday period. The pain level of the patients was evaluated using a numerical rating scale; - before the femoral sheath extraction (PAS1), - during the femoral sheathing (SDQ2), - immediately after the femoral sheathing (SDQ3), - 30 minutes after the femoral sheathing (SDQ4) and - 1 hour after the femoral sheathing (SDQ4). SDÖ5) was evaluated and recorded.


Recruitment information / eligibility

Status Completed
Enrollment 108
Est. completion date January 4, 2023
Est. primary completion date November 3, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Intervention in the femoral region, - Femoral sheath size is 6-7 fr, - Presence of only one sheath in the femoral region, - No analgesics were administered before femoral sheath removal, - Absence of serious bleeding and major hematoma in the femoral region, - Being over 18 years of age, - No communication problems, - Having a place and time orientation, - No dizziness, - Not having any psychiatric disease, - No visual, auditory or mental problems, - No previously identified cold allergy, - Being willing and willing to participate in the study, Exclusion Criteria: - Serious bleeding and major hematoma development in the femoral region, - Not applying intracoronary stent or coronary angioplasty after coronary angiography, - Vital signs are abnormal enough to prevent intervention, - Having visual, auditory and mental disabilities, - Having a communication problem, - Not being willing and able to participate in the study, - It is defined as wanting to withdraw from the study at any stage of the study or being excluded from the study by the researcher.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual Reality Glasses
Preparation Stage of Virtual Glasses: A 20-minute video consisting of nature scenes shot with a 360-degree camera was selected by the researchers from YouTube. Permission was obtained from the person who created the video. For the selection of music, both the music that is good for diseases were examined in the literature and an expert opinion was taken from a faculty member (Phd, assistant professor) working at the Faculty of Music and Fine Arts of a university. The music used in the video was created with works selected from the Hüseyni maqam.
Ice Application Group
Features of the ice and ice bag used for patients in ice application; Ice cubes with dimensions of 9.5 x 26 x 3.5 cm were used. The ice bag is made of cotton and polyester coated fabric and is easily bendable. In this way, the ice bag was ensured to fit properly to the patient's femoral region. It is reusable and heat insulated. The procedure was carried out by following the cold application step protocol created by the researchers using the literature.
Control Group
They continued to receive their routine treatment and care. No changes were made in their routine treatment and care.

Locations

Country Name City State
Turkey Amasya University Institute of Health Sciences Amasya Merkez

Sponsors (1)

Lead Sponsor Collaborator
Amasya University

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Paice JA, Cohen FL. Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nurs. 1997 Apr;20(2):88-93. doi: 10.1097/00002820-199704000-00002. — View Citation

Wang HL, Keck JF. Foot and hand massage as an intervention for postoperative pain. Pain Manag Nurs. 2004 Jun;5(2):59-65. doi: 10.1016/j.pmn.2004.01.002. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Questionnaire The patients' opinions regarding the application of ice and virtual reality glasses were evaluated. "through study completion, an average of 1 year".
Primary Pain Scores: Numerical rating scale The Numeric Rating Scale is a pain screening tool, commonly used to assess pain severity at that moment in time using a min:0-max:10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable" (10). This scale is a valid and reliable scale developed to determine the pain level of patients. The numerical rating scale simplifies the description of the pain level by the patient and makes it easier for the monitoring nurse to record the patient's pain rating. That the pain increases as the score increases, and then the patient verbally tells the numerical value of the pain intensity he/she feels. Pain score was measured before femoral sheath removal (time 1), and, during femoral sheath removal (2nd time),and, immediately after femoral sheath removal (3rd time), and 30 minutes after femoral sheath removal (4th time), and1 hour after femoral sheath removal (5th time). "through study completion, an average of 1 year".
Secondary Physiological parameter Vital parameters (Pulse rate measured in minutes) of the patients were evaluated
Pulse rate was measured before femoral sheath removal (time 1) Pulse rate was measured during femoral sheath removal (2nd time) Pulse rate was measured immediately after femoral sheath removal (3rd time) Pulse rate was measured 30 minutes after femoral sheath removal (4th time) Pulse rate was measured 1 hour after femoral sheath removal (5th time
"through study completion, an average of 1 year".
Secondary Physiological parameter Vital parameters (respiration-rate measured in minutes) of the patients were evaluated.
Respiration rate was measured before femoral sheath removal (time 1) Respiration rate was measured during femoral sheath removal (2nd time) Respiration rate was measured immediately after femoral sheath removal (3rd time) Respiration rate was measured 30 minutes after femoral sheath removal (4th time) Respiration rate was measured 1 hour after femoral sheath removal (5th time)
"through study completion, an average of 1 year".
Secondary Physiological parameter Vital parameters (blood pressure-measured in mmHg) of the patients were evaluated
Blood pressure was measured before femoral sheath removal (time 1) Blood pressure was measured during femoral sheath removal (2nd time) Blood pressure was measured immediately after femoral sheath removal (3rd time) Blood pressure was measured 30 minutes after femoral sheath removal (4th time) Blood pressure was measured 1 hour after femoral sheath removal (5th time)
"through study completion, an average of 1 year".
Secondary Physiological parameter Vital parameters (body temperature measured in degrees Centigrant) of the patients were evaluated
Body temperature was measured before femoral sheath removal (time 1) Body temperature was measured during femoral sheath removal (2nd time) Body temperature was measured immediately after femoral sheath removal (3rd time) Body temperature was measured 30 minutes after femoral sheath removal (4th time) Body temperature was measured 1 hour after femoral sheath removal (5th time)
"through study completion, an average of 1 year".
See also
  Status Clinical Trial Phase
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Not yet recruiting NCT05669222 - The FAVOR V AMI Trial N/A
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05240781 - Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk N/A
Recruiting NCT03378934 - Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention Phase 4
Not yet recruiting NCT06025071 - Residual Inflammatory Risk-Guided colcHicine in Elderly Trial Phase 4
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Completed NCT03085823 - The All-comers Sirolimus-coated Balloon European Registry
Completed NCT02837744 - Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure
Completed NCT02044146 - A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk Phase 2/Phase 3
Completed NCT03131271 - Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention N/A
Completed NCT01156571 - A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX) Phase 3
Completed NCT01135667 - Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI Phase 4
Unknown status NCT00751491 - Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI) Phase 3
Completed NCT00725868 - Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention N/A
Completed NCT03708588 - Chewed Versus Integral Pill of Ticagrelor Phase 4
Completed NCT04163393 - R-One Efficiency For PCI Evolution With Robotic Assistance N/A
Recruiting NCT05554588 - Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI N/A
Recruiting NCT06080919 - Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI). N/A
Recruiting NCT05353140 - LAAO Versus NOAC in Patients With AF and PCI N/A